Jeff Stevens on the Healing Potential of Amanita Muscaria Mushrooms

CSE's Anil Mall chats with Jeff Stevens, CEO of Psyched Wellness Ltd. (CSE:PSYC) to discuss the company's objective to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. Jeff also shares how they are developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief and relaxation, assist with sleeping and to support mood.

Here's an overview of what Anil and Jeff cover in this edition of the #HashtagFinance podcast:

0:00 - Introducing Jeff Stevens CEO of Psyched Wellness
2:30 - The company's mission to harness the healing power of mushrooms
6:00 - The science and history of Amanita Muscaria
9:00 - Professor David Nutt - a thought leader in Amanita Muscaria
11:20 - Michael Nederhoff, Terry Booth and the PSYC Board
16:00 - Psyched's developing product line
17:20 - The R&D required to launch a micro dose product
20:30 - Keeping up with Psyched
22:50 - Closing comments - the value proposition

Learn more about Psyched Wellness at: https://thecse.com/en/listings/life-sciences/psyched-wellness-ltd 

  Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe

STAY CONNECTED WITH THE CSE 
=============================

- PODCAST: https://blog.thecse.com/pe-podcasts/
- INSTAGRAM: https://www.instagram.com/canadianexchange/
- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
- TWITTER: https://twitter.com/CSE_News
- BLOG: https://blog.thecse.com/
- WEBSITE: https://thecse.com/

MB018AGQFSDIUC6